Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Common Stock | Options Exercise | $0 | +208 | $0.00 | 208 | May 6, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Award | $0 | +609 | $0.00 | 609 | May 6, 2024 | Common Stock | 609 | $476.87 | Direct | F1 | |
transaction | IDXX | Deferred Stock Unit | Award | $0 | +262 | $0.00 | 262 | May 6, 2024 | Common Stock | 262 | Direct | F2 | ||
transaction | IDXX | Restricted Stock Unit | Options Exercise | $0 | -208 | -100% | $0.00* | 0 | May 6, 2024 | Common Stock | 208 | Direct | F3 |
Id | Content |
---|---|
F1 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier. |
F2 | Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. |
F3 | Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event was earlier. |